Table 3:
Unadjusted Hazard Ratio (95% CI) | Adjusted Hazard Ratio (95% CI) | P-value | |
---|---|---|---|
Glycated hemoglobin (HbA 1C ) | |||
≤5.7 % | 1 (Reference) | 1 (Reference) | |
5.7 – 6.4 % | 1.12 (0.72, 1.77) | 0.84 (0.52, 1.33) | 0.45 |
≥ 6.5 % | 2.90 (1.88, 4.45) | 1.65 (1.03, 2.62) | 0.0355 |
1 SD increment of HbA 1C | 1.38 (1.24, 1.52) | 1.30 (1.12, 1.51) | 0.0007 |
Fasting Plasma Glucose (mg/dL) | |||
<100 mg/dL | 1 (Reference) | 1 (Reference) | |
100–125 mg/dL | 1.19 (0.78, 1.81) | 0.81 (0.51, 1.26) | 0.34 |
≥ 125 mg/dL | 3.13 (2.00, 4.89) | 1.92 (1.20, 3.08) | 0.0070 |
1-SD increment of fasting Glucose | 1.29 (1.17, 1.42) | 1.32 (1.17, 1.48) | <0.0001 |
Hyperglycemia status (defined by both fasting plasma glucose and HbA 1C ) | |||
Normal | 1 (Reference) | 1 (Reference) | |
Pre-diabetes | 0.96 (0.58, 1.57) | 0.68 (0.41, 1.13) | 0.14 |
Diabetes | 2.36 (2.03, 3.79) | 1.24 (1.02, 2.05) | 0.03 |
Values are hazard ratios (95% confidence interval [CI]) and P values. The hazard ratios are adjusted for age, sex, smoking, income, alcohol use, physical activity, body mass index, ratio of total to HDL-cholesterol, systolic blood pressure, use of antihypertensive medications, use of statins, eGFR, and CHD (time-varying covariate).